Comparisons14 min readUpdated 2025-12-16

    Mounjaro Shortage 2026: Compounded Alternatives Available

    Complete guide covering Mounjaro supply challenges and tirzepatide alternatives in 2026. Compare options, understand pricing, and see how compounded GLP-1 treatment through telehealth works.

    Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. This article provides comprehensive, medically reviewed information about Mounjaro supply challenges and tirzepatide alternatives to help patients make informed treatment decisions.

    Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.

    Understanding Mounjaro Shortage 2026

    This article examines Mounjaro supply challenges and tirzepatide alternatives in the context of this evolving market, providing patients with the information they need to evaluate their options and make decisions that align with their health goals and financial reality. Whether you are considering semaglutide or tirzepatide, understanding the current landscape is essential for making an informed choice.

    Frequently Asked Questions

    What should patients know about Mounjaro supply challenges and tirzepatide alternatives?

    Patients exploring GLP-1 medications for weight loss in 2026 have more options than ever. Brand-name medications like Wegovy, Ozempic, Mounjaro, and Zepbound have proven clinical effectiveness but carry retail prices of $900 to $1,500 per month. Compounded semaglutide and compounded tirzepatide are available through telehealth providers like Trimi starting at $99 to $125 per month, making treatment accessible to millions more patients.

    How do compounded GLP-1 medications compare to brand-name options?

    Brand-name products like Wegovy, Ozempic, Mounjaro, and Zepbound are FDA-approved finished drugs made by their manufacturers. Compounded semaglutide and compounded tirzepatide are prepared by state-licensed compounding pharmacies against an individual prescription and are not FDA-approved as drugs. The two categories also differ in delivery device, supply chain, and price. Whether a compounded preparation is appropriate for you is a decision for your prescribing clinician.

    Is compounded semaglutide or tirzepatide safe?

    Compounded GLP-1 medications from accredited pharmacies are generally considered safe. They are prepared per individual prescription and are not FDA-approved as drugs. Quality depends on the compounding pharmacy, patients should choose providers that partner with PCAB-accredited or FDA-registered 503A community sterile-compounding pharmacy that conduct third-party potency and sterility testing. Trimi meets all of these quality standards.

    How much does compounded GLP-1 treatment cost through Trimi?

    Through Trimi, compounded semaglutide starts at $99 per month and compounded tirzepatide starts at $125 per month. Pricing is flat and published up front, and it covers the clinical evaluation, ongoing provider support, and the medication itself, so you can work out the full twelve-month cost, $1,188 for semaglutide or $1,500 for tirzepatide, before you start. No insurance, prior authorization, or separate consultation fee is required.

    Do I need insurance to get compounded GLP-1 medications?

    No, compounded GLP-1 medications through Trimi do not require insurance coverage. Treatment is available at transparent monthly prices with no prior authorization, no coverage denials, and no formulary restrictions. This makes compounded options particularly valuable for uninsured patients, those on Medicare or Medicaid, and those whose insurance does not cover weight loss medications.

    How do I get started with compounded GLP-1 treatment?

    Through Trimi, the process starts with an online health assessment covering your medical history, medications, and weight loss goals. A board-certified provider reviews your information, typically within 24 hours, and prescribes the appropriate medication if clinically appropriate. Your medication is prepared by an accredited compounding pharmacy and shipped free overnight to your door once compounded.

    Can I switch from a brand-name medication to compounded?

    Switching is a clinical decision, so start by telling your provider exactly what you are taking now, at what dose, and when your last injection was. If they decide a compounded preparation is appropriate for you, they will set the dose and the titration schedule, including whether any adjustment is needed. Compounded preparations are made against an individual prescription, are not FDA-approved as drugs, and have not been studied in clinical trials of their own, so never change or stop a prescribed medication on your own.

    Sources & References

    1. STEP 1 trial: semaglutide 2.4mg for weight management (NEJM, 2021).
    2. SURMOUNT-1 trial: tirzepatide for obesity (NEJM, 2022).
    3. FDA guidance on drug compounding regulations.
    4. FDA drug shortage database.
    5. NABP compounding pharmacy accreditation standards.
    6. NIDDK overview of prescription weight loss medications.
    7. Wegovy prescribing information from the FDA.
    8. Zepbound prescribing information from the FDA.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Trimi provides compounded GLP-1 medications, this article aims to be informative and balanced, but readers should be aware of our perspective.

    Is Mounjaro still in shortage in 2026?

    No. The FDA officially declared the tirzepatide shortage resolved in December 2024, and Mounjaro is not on the FDA Drug Shortages list in 2026. Pharmacy-level supply of brand Mounjaro has stabilized, and patients with adequate insurance coverage and approved prior authorization typically have no difficulty filling prescriptions. The shortage resolution had a major regulatory consequence for compounded tirzepatide: 503A community compounding pharmacies can no longer compound tirzepatide based on the shortage exception. They can only continue under patient-specific clinical justification (e.g., need for a different concentration than commercial product, or documented allergy to inactive ingredients). 503B outsourcing facilities have a narrower pathway to produce compounded tirzepatide for clinically justified individualized needs not met by commercial products. The primary access barriers in 2026 are insurance coverage and copay, not physical supply.

    Tirzepatide shortage resolved by FDA in December 2024.
    503A pharmacies lost compound-during-shortage exception; patient-specific only.
    Primary 2026 barriers are insurance and copay, not pharmacy supply.

    Key Takeaways

    • FDA declared the tirzepatide shortage resolved in December 2024; Mounjaro is no longer on the FDA Drug Shortages list as of 2026.
    • Resolution of the shortage means 503A pharmacies can no longer compound tirzepatide based on shortage exception, only patient-specific clinical justification.
    • 503B outsourcing facilities still have a narrow pathway to produce compounded tirzepatide for clinically justified individualized patient needs not met by commercial products.
    • Pharmacy-level supply of brand Mounjaro has stabilized, but coverage and copay assistance remain the primary access barriers, not physical supply.
    • Patients with adequate insurance coverage typically have no difficulty filling Mounjaro prescriptions in 2026 once prior authorization is approved.
    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Dr. Sean Arora, MD

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    - Amy K.Facebook
    Just recieved my order today. I placed order Monday afternoon and arrived this afternoon. Everything packaged great, clear instructions to follow. The customer service was excellent. I have tried other companies, but this is the most affordable by far. I am almost at my goal weight.

    Outcome: Next-day arrival; most affordable tried; near goal weight

    - Raquel R.Facebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Eli Lilly and Company (2025). Mounjaro (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    2. U.S. Food and Drug Administration (2025). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA.Read Study
    3. U.S. Food and Drug Administration (2026). FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Complete guide covering purchasing tirzepatide online in the United States in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications are prescribed and dispensed through licensed telehealth.

    Complete guide covering the most affordable Mounjaro alternative available in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications are prescribed and dispensed through licensed telehealth.

    Complete guide covering ordering tirzepatide online through telehealth in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications are prescribed and dispensed through licensed telehealth.

    Complete guide covering affordable tirzepatide options without insurance in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications are prescribed and dispensed through licensed telehealth.

    Start your GLP-1 journey, from $99/mo

    Get Started